Autolus Therapeutics plc 10-K filing
Filed 2026-03-27 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001730463-26-000038
- Form type
- 10-K
- CIK
- 0001730463
- Primary document
- https://www.sec.gov/Archives/edgar/data/1730463/000173046326000038/autl-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Autolus Therapeutics plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $75.4M | - | - |
| Cost Of Revenue | $96.4M | - | - |
| Operating Income | $-270.5M | - | - |
| Net Income | $-287.5M | - | - |
| Eps Basic | -1.08 | - | - |
| Eps Diluted | -1.08 | - | - |
| Cash And Equivalents | $104.1M | - | - |
| Total Assets | $589.1M | - | - |
| Total Liabilities | $410.9M | - | - |
| Shareholders Equity | $178.1M | - | - |
| Operating Cash Flow | $-283.6M | - | - |
| Capital Expenditures | $19.0M | - | - |